Ignite Creation Date:
2024-05-06 @ 8:36 AM
Last Modification Date:
2024-10-26 @ 12:02 PM
Study NCT ID:
NCT02775006
Status:
TERMINATED
Last Update Posted:
2019-04-30
First Post:
2016-04-12
Brief Title:
Docetaxel Versus Intercalated Erlotinib-docetaxel in Patients With Relapsed EGFR Wild Type ALK Negative Non Squamous Cell Carcinoma
Sponsor:
The Netherlands Cancer Institute
Organization:
The Netherlands Cancer Institute
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-10-14
Start Date Type:
ACTUAL
Primary Completion Date:
2019-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-04
Completion Date Type:
ACTUAL
First Submit Date:
2016-04-12
First Submit QC Date:
May 12 2016
Study First Post Date:
2016-05-17
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-04-26
Last Update Post Date:
2019-04-30
Last Update Post Date Type:
ACTUAL